Evidence map›Paper›PMID 41832417›Full record

ReviewCellular & molecular biology letters2026

Post-translational modifications of selective autophagy receptors: orchestrating cellular homeostasis, disease pathogenesis, and therapeutic opportunities.

Wenyun Zhu, Xiaohui Wang, Qing Li, Xiaogang Jiang, Guoqiang Xu

Abstract readReview
In one paragraph

Review in Cellular & molecular biology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenyun ZhuJiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, The Fourth Affiliated Hospital of Soochow University, Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-Communicable Diseases, Suzhou Key Laboratory of Drug Research for Prevention and Treatment of Hyperlipidemic Diseases, Soochow University, 199 Ren'ai Road, Suzhou, 215123, Jiangsu, China.
Xiaohui WangJiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, The Fourth Affiliated Hospital of Soochow University, Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-Communicable Diseases, Suzhou Key Laboratory of Drug Research for Prevention and Treatment of Hyperlipidemic Diseases, Soochow University, 199 Ren'ai Road, Suzhou, 215123, Jiangsu, China.
Qing LiSuzhou Key Laboratory of Geriatric Neurological Disorders, Department of Gastroenterology, The First People's Hospital of Taicang, Taicang Affiliated Hospital of Soochow University, Suzhou, 215400, Jiangsu, China.
Xiaogang JiangJiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, The Fourth Affiliated Hospital of Soochow University, Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-Communicable Diseases, Suzhou Key Laboratory of Drug Research for Prevention and Treatment of Hyperlipidemic Diseases, Soochow University, 199 Ren'ai Road, Suzhou, 215123, Jiangsu, China. jiangxiaogang@suda.edu.cn.
Guoqiang XuJiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, The Fourth Affiliated Hospital of Soochow University, Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-Communicable Diseases, Suzhou Key Laboratory of Drug Research for Prevention and Treatment of Hyperlipidemic Diseases, Soochow University, 199 Ren'ai Road, Suzhou, 215123, Jiangsu, China. gux2002@suda.edu.cn.

Funding

National Natural Science Foundation of China 32171437
6 · The paper itself

Abstract

Selective autophagy, an evolutionarily conserved quality control process, preserves cellular homeostasis by degrading specific substrates or organelles. Autophagy receptors, which precisely recognize and target substrates through sophisticated molecular mechanisms, are central to this pathway. These receptors orchestrate diverse biological functions ranging from DNA damage response, protein degradation, proteostasis, neuronal health, to immune modulation. Increasing evidence suggests that posttranslational modifications (PTMs) critically regulate the biological functions of autophagy receptors, forming a complex regulatory network that remains incompletely characterized in disease pathogenesis. This review first summarizes current knowledge of mammalian autophagy, including the principal molecular machinery across diverse pathways. We then categorize autophagy receptors on the basis of cargo specificity, and highlight PTM-mediated regulatory mechanisms. Furthermore, we explore their pathophysiological roles and assess their therapeutic potential by integrating recent advances. Finally, we discuss emerging perspectives in the autophagy research field, especially for the discovery of pathology-associated PTMs that modulate the functions of autophagy receptors. A deeper understanding of autophagic regulation and its pathophysiological significance will advance innovative therapeutic strategies targeting diseases associated with autophagy dysfunction.

Indexed as

AutophagyHomeostasisProtein Processing, Post-TranslationalAnimalsHumansProteostasisAutophagy receptorDisease pathogenesisPosttranslational modificationProteostasisSelective autophagy

Identifiers

PMID41832417
PMCPMC13104377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.